urc mondor

Unité de Recherche Clinique Henri Mondor

Long-term follow-up of the STOPAGO study.

Cottu A, Guillet S, Viallard J-F, Rivière E, Cheze S, Gobert D, Neel A, Graveleau J, Marolleau J-P, Lefrère F, Moulis G, Lega J-C, Moignet-Autrel A, Robbins A, Crickx E, Boutin E, Noel N, Malphettes M, Galicier L, Audia S, Bonnotte B, Lambotte O, Fain O, Gerfaud-Valentin M, Terriou L, Martis N, Morin A-S, Perlat A, Le Gallou T, Roy-Peaud F, Puyade M, Comont T, Limal N, Languille L, Michel M, Godeau B, Mahévas M Blood. 2025;145(2):244-247.

<p>In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained a sustained response off treatment 4 years after treatment discontinuation.</p>

MeSH terms: Adult; Aged; Chronic Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Thrombopoietin
DOI: 10.1182/blood.2024025707
PubMed Google Scholar